Contract facts
UnrestrictedTo Carry Out Development for a Drug Candidate Small Molecule Inhibitor Against Chikungunya Virus, an Alphavirus That Ca… is a federal Unrestricted award for National Institutes Of Health Niaid held by Oregon Health & Science University. Estimated value $15M ($7.4M obligated). Current period of performance ends May 31, 2027. Last award drew 10 bidders. Place of performance: PORTLAND OR. Related solicitation BAA2022-1.
To carry out development for a drug candidate small molecule inhibitor against chikungunya virus, an alphavirus that causes debilitating and sometimes life-threatening disease in humans. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends May 31, 2027 (222 days remaining). Agencies typically plan 12–18 months ahead — at 7.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N93023C00002? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOregon Health & Science University — $69.0M obligated across 216 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93023C00002?
75N93023C00002 (Carry out development for a drug) is a National Institutes Of Health Niaid award with a potential value of $15M, currently held by Oregon Health & Science University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93023C00002?
National Institutes Of Health Niaid awarded 75N93023C00002 to Oregon Health & Science University (potential $15M).
Who is the incumbent on 75N93023C00002?
Oregon Health & Science University is the incumbent with $69.0M across 216 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2027.
When does Oregon Health & Science University’s 75N93023C00002 come up for recompete?
SCOUT tracks a period-of-performance end of May 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N93023C00002? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.